Search Results

Filter
  • 1-10 of  4,557 results for ""Gout Suppressants""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction.

  • Authors : Iwama R; Translational Science Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited, Tokyo, Japan.; Nishida K

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/pharmacokinetics ; Febuxostat*/Febuxostat*/Febuxostat*/administration & dosage ; Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Dec; Vol. 12 (6), pp. e70032.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

Record details

×
Academic Journal

Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.

  • Authors : Helget LN; Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: .

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use ; Febuxostat*/Febuxostat*/Febuxostat*/adverse effects ; Gout*/Gout*/Gout*/drug therapy

  • Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2024 Nov; Vol. 84 (5), pp. 538-545. Date of Electronic Publication: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.

  • Authors : Barry A; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.; Helget LN

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use ; Febuxostat*/Febuxostat*/Febuxostat*/administration & dosage ; Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Oct; Vol. 76 (10), pp. 1552-1559. Date of Electronic Publication: 2024 Jul 15.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Baseline Dual-Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate-Lowering Therapy.

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout*/Gout*/Gout*/diagnostic imaging ; Gout*/Gout*/Gout*/blood

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Dec; Vol. 76 (12), pp. 1657-1665. Date of Electronic Publication: 2024 Aug 29.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate-Lowering Therapy During Remission: A Mixed-Methods Study.

  • Authors : Peeters IR; Sint Maartenskliniek, Ubbergen, the Netherlands and Radboud University, Nijmegen, the Netherlands.; Veenstra F

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout*/Gout*/Gout*/blood ; Gout Suppressants*/Gout Suppressants*/Gout Suppressants*/therapeutic use

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Nov; Vol. 76 (11), pp. 1574-1583. Date of Electronic Publication: 2024 Jul 23.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol.

  • Authors : Fanning NC; Department of Medicine, University of Otago, Christchurch, Aotearoa, New Zealand.; Cadzow M

Subjects: Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use ; Gout*/Gout*/Gout*/genetics ; Gout*/Gout*/Gout*/drug therapy

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Nov 01; Vol. 63 (11), pp. 3025-3032.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating Allopurinol.

  • Authors : Tabi-Amponsah AD; A.D. Tabi-Amponsah, BBiomedSc(Hons), A. Horne, MBChB, G. Gamble, MSc, N. Dalbeth, MD, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.; Stamp LK

Subjects: Colchicine*/Colchicine*/Colchicine*/therapeutic use ; Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use ; Gout*/Gout*/Gout*/drug therapy

  • Source: The Journal of rheumatology [J Rheumatol] 2024 Nov 01; Vol. 51 (11), pp. 1135-1140. Date of Electronic Publication: 2024 Nov 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Predicting Gout Flares in People Starting Allopurinol Using the Start-Low Go-Slow Dose Escalation Strategy.

  • Authors : Stamp LK; University of Otago, Christchurch, Christchurch, and Te Whatu Ora, Waitaha, New Zealand.; Horne A

Subjects: Allopurinol*/Allopurinol*/Allopurinol*/administration & dosage ; Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use ; Gout*/Gout*/Gout*/drug therapy

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Oct; Vol. 76 (10), pp. 1371-1378. Date of Electronic Publication: 2024 Jun 05.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adherence and Treat-to-Target Benchmarks in Older Adults With Gout Initiating Urate-Lowering Therapy in Ontario, Canada: A Population-Based Study.

  • Authors : Kwok TSH; University of Toronto and Sunnybrook Research Institute, Holland Bone & Joint Program, Toronto, Ontario, Canada.; Kuriya B

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout*/Gout*/Gout*/blood ; Gout Suppressants*/Gout Suppressants*/Gout Suppressants*/therapeutic use

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Oct; Vol. 76 (10), pp. 1379-1389. Date of Electronic Publication: 2024 Jun 23.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials.

  • Authors : Yang XH; Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China.; Department of Nephrology, Huadong Hospital, Fudan University, Shanghai, China.

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use ; Febuxostat*/Febuxostat*/Febuxostat*/pharmacology ; Glomerular Filtration Rate*/Glomerular Filtration Rate*/Glomerular Filtration Rate*/drug effects

  • Source: Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2332956. Date of Electronic Publication: 2024 May 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  4,557 results for ""Gout Suppressants""